Peyronies disease (PD) is a connective tissue disorder of the penis characterized by fibrosis and the formation of plaque within the tunica albuginea, leading to penile curvature, shortened penis size, and erectile dysfunction
This approach serves several important purposes: Preventing Desensitization Continuous receptor stimulation can lead to: Reduced receptor response Diminished effectiveness Need for higher doses Wasted resources Maintaining Natural Function Breaks allow your body to: Reset receptor sensitivity Maintain natural hormone production Prevent dependency development Assess baseline function The Science of Receptor Sensitivity What Happens with Continuous Use Initial use: Strong receptor response Weeks later: Receptors begin downregulating Months later: Diminished response despite same dose Result: Need higher doses for same effect How Cycling Helps Active phase: Receptors respond well Break phase: Receptors upregulate Resume: Full response restored Long-term: Sustained effectiveness Cycling Guidelines by Peptide Type GH Secretagogues (CJC-1295, Ipamorelin, etc.) Notes: GHRPs may desensitize faster than GHRH analogs Consider alternating between different GHRPs Pulsatile dosing may reduce desensitization Healing Peptides (BPC-157, TB-500) Notes: Less prone to desensitization Often used until healing goals achieved Can use PRN after initial protocol GLP-1 Agonists (Semaglutide, Tirzepatide) Notes: Weight regain common upon stopping Usually used as long-term therapy Discuss with healthcare provider PT-141 (Bremelanotide) Notes: Not for daily use Tolerance can develop Built-in limitation by design How to Structure Your Cycles Planning Your Cycle Define goals : What are you trying to achieve
When Inhaled: Limited information is available regarding the safety of inhaled glutathione, but its generally considered safe
Its clinical manifestations include itchy, erythematous papules and patches, and sometimes vesicles arranged in a reticular pattern (234, 235)
